MILANO (AIMnews.it) – Sucrosomial Technology®, a patent of the PharmaNutra Group, the protagonist of two recent publications released last week in many prestigious international magazines. These publications are the results of collaborations between the Scientific management of PharmaNutra and important Italian Universities with strong expertise in the study of the metabolism of iron. In one of the first articles published in the International Journal of Molecular Sciences, created together with the University of Pisa, entitled “Ex Vivo and in Vivo Study of Sucrosomial® Iron Intestinal Absorption and Bioavailability”, new evidence was demonstrated on the kinetic absorption of Iron Sucrosomiale®. Furthermore, the study demonstrates that Sucrosomalous Iron can allow greater bioavailability in the bone marrow, where the erythropoietic process takes place. The second piece, “Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation”, published in the journal ‘Nutrients’ was carried out at the University of Brescia and the University of Verona. It should be noted that the use of Sucrosomial® Iron does not determine a pro-oxidant effect compared to conventional ferrous sulfate, thus giving a further interesting indication on the use of Sideral® products, based on Sucrosomiale® iron.